Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease

Author(s): D. George, A. Salmeron.

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 7 , 2009

Become EABM
Become Reviewer

Abstract:

Cot/Tpl-2/MAP3K8 is a serine/threonine protein kinase that is essential for lipopolysaccharide (LPS)-induced activation of the MEK/ERK pathway in macrophages as demonstrated in Cot/Tpl-2-deficient mice. Cot/Tpl-2 kinase activation plays an integral role in the production of pro-inflammatory cytokines such as TNF and IL-1β in this immune cell type. Elevated levels of these cytokines have been clinically implicated as mediators of a number of autoimmune diseases, in particular, the pain and joint destruction of rheumatoid arthritis. By inference, pharmaceutical agents that inhibit Cot/Tpl-2 kinase have the potential to be novel and effective therapies for the treatment of these diseases. This review will describe the physiological regulation and importance of Cot/Tpl-2 in inflammation as well as the landscape of small molecules that have been reported as Cot/Tpl-2 inhibitors.

Keywords: Cot/Tpl-2, serine/threonine kinase, LPS, macrophages, kinase inhibitors

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 7
Year: 2009
Page: [611 - 622]
Pages: 12
DOI: 10.2174/156802609789007345
Price: $58

Article Metrics

PDF: 29